Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-10-16 7:42 pm Sale | 2026-10-14 | 13D | COMSTOCK INC PAR $0.000666 LODE | MAK Capital Fund LP | 3,959,115 5.200% | -1,106,541 (-21.84%) | Filing History |
| 2026-09-16 7:57 pm Sale | 2026-09-14 | 13D | COMSTOCK INC PAR $0.000666 LODE | MAK Capital Fund LP | 5,065,656 6.700% | -698,073 (-12.11%) | Filing History |
| 2026-05-15 6:12 pm Purchase | 2026-03-31 | 13G | STANDARD BIOTOOLS INC. LAB | MAK Capital Fund LP | 26,172,626 6.700% | 6,205,061 (+31.08%) | Filing History |
| 2026-05-15 5:13 pm Purchase | 2026-03-31 | 13G | CLEARPOINT NEURO INC CLPT | MAK Capital Fund LP | 1,901,489 6.300% | 171,878 (+9.94%) | Filing History |
| 2026-05-15 3:04 pm Purchase | 2026-03-31 | 13G | AUTOLUS THERAPEUTICS PLC SPONS AUTL | MAK Capital Fund LP | 33,621,487 12.600% | 3,616,144 (+12.05%) | Filing History |
| 2026-05-01 5:01 pm Purchase | 2026-04-29 | 13D | EVOTEC SE AMERICAN DEPOSITARY EVO | MAK Capital Fund LP | 12,681,898 7.100% | 178,386 (+1.43%) | Filing History |
| 2026-04-06 12:56 pm Unchanged | 2026-04-01 | 13D | EVOTEC SE AMERICAN DEPOSITARY EVO | MAK Capital Fund LP | 12,503,512 7.000% | 0 (Unchanged) | Filing History |
| 2026-03-30 8:29 pm Purchase | 2026-03-30 | 13D | EVOTEC SE AMERICAN DEPOSITARY EVO | MAK Capital Fund LP | 12,503,512 7.000% | 3,117,078 (+33.21%) | Filing History |
| 2026-03-30 5:31 pm Sale | 2026-03-24 | 13G | PROTALIX BIOTHERAPEUTICS INC C PLX | MAK Capital Fund LP | 3,616,289 4.500% | -1,033,310 (-22.22%) | Filing History |
| 2026-03-25 4:26 pm Purchase | 2026-03-23 | 13D | COMSTOCK INC PAR $0.000666 LODE | MAK Capital Fund LP | 5,763,729 8.100% | 311,575 (+5.71%) | Filing History |
| 2026-03-13 4:34 pm Purchase | 2026-03-10 | 13G | CLEARPOINT NEURO INC CLPT | MAK Capital Fund LP | 1,729,611 6.100% | 1,729,611 (New Position) | Filing History |
| 2026-03-12 4:17 pm Sale | 2026-03-09 | 13G | TALKSPACE INC TALK | MAK Capital Fund LP | 6,929,273 4.200% | -1,672,416 (-19.44%) | Filing History |
| 2026-03-04 4:40 pm Purchase | 2026-02-26 | 13G | PROTALIX BIOTHERAPEUTICS INC C PLX | MAK Capital Fund LP | 4,649,599 5.800% | 4,649,599 (New Position) | Filing History |
| 2026-03-02 5:08 pm Purchase | 2026-02-24 | 13G | TALKSPACE INC TALK | MAK Capital Fund LP | 8,601,689 5.200% | 8,601,689 (New Position) | Filing History |
| 2026-02-13 4:07 pm Purchase | 2025-12-31 | 13G | AUTOLUS THERAPEUTICS PLC SPONS AUTL | MAK Capital Fund LP | 30,005,343 11.300% | 3,117,835 (+11.60%) | Filing History |
| 2026-02-13 4:05 pm Purchase | 2025-12-31 | 13G | DIRTT ENVIRONMENTAL SOLUTIONS DRTTF | MAK Capital Fund LP | 9,081,696 4.700% | 9,081,696 (New Position) | Filing History |
| 2026-02-05 4:00 pm Purchase | 2026-01-29 | 13G | COMSTOCK INC PAR $0.000666 LODE | MAK Capital Fund LP | 5,452,154 7.600% | 5,452,154 (New Position) | Filing History |
| 2026-01-16 4:06 pm Purchase | 2026-01-09 | 13G | EVOTEC SE AMERICAN DEPOSITARY EVO | MAK Capital Fund LP | 9,386,434 5.300% | 9,386,434 (New Position) | Filing History |
| 2026-01-07 5:42 pm Purchase | 2025-12-31 | 13G | STANDARD BIOTOOLS INC. LAB | MAK Capital Fund LP | 19,967,565 5.190% | 19,967,565 (New Position) | Filing History |
| 2025-12-03 4:04 pm Purchase | 2025-12-01 | 13G | AUTOLUS THERAPEUTICS PLC SPONS AUTL | MAK Capital Fund LP | 26,887,508 10.100% | 11,478,870 (+74.50%) | Filing History |